Orapuh Institute

A new mRNA vaccine for pancreatic cancer creates lasting immunity in patients.

A groundbreaking clinical trial has demonstrated that a personalized mRNA vaccine can trigger a long-lasting immune response against pancreatic cancer, one of the deadliest and most treatment-resistant malignancies.

Published in the journal Nature, the Phase 1 study evaluated autogene cevumeran, an investigational vaccine developed by BioNTech and Genentech. Tailored to the unique genetic mutations of each patient’s tumor, the vaccine works by training the body’s immune system to recognize and attack malignant cells. When administered alongside standard chemotherapy and immunotherapy, the vaccine successfully triggered tumor-specific T-cell responses in half of the 16 study participants.

Crucially, patients who mounted this robust immune response experienced a significantly lower risk of cancer recurrence during a three-year follow-up period.

Researchers observed that these vaccine-activated T cells persisted in some patients' bodies for up to four years, proving that mRNA technology can provide durable oncological protection. While pancreatic cancer has historically carried a bleak prognosis, this highly personalized approach offers a promising new frontier.

A larger Phase 2 trial is currently underway, enrolling 260 patients worldwide to determine whether this customized vaccine can fundamentally improve long-term survival outcomes compared to standard care.

Source: Sethna, Z., Guasp, P., Reiche, C., et al. RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer. Nature, 639(1042–1051) (as reported by Hashem Al-Ghaili).

The aim of the new trial is to “train the immune system with a vaccine” to recognise abnormalities and stop them developing into cancer.
https://www.independent.co.uk/news/health/colorectal-cancer-vaccine-lynch-syndrome-b2992236.html?fbclid=IwdGRjcASWyyFjbGNrBJaTa2V4dG4DYWVtAjExAHNydGMGYXBwX2lkDDM1MDY4NTUzMTcyOAABHnv45v4_A0kX4ikh0fmsBrs_Mk9rYxAM5S95AFZwdfEsfkPdqtNcOYJhklu0_aem_WA4k1Jsq0bApfILrA3ExXQ

Source: The Independent

Remote work has increased isolation and harmed mental health for millions of workers, research shows.

When the pandemic forced millions of Americans to work from home, researcher Emma Harrington was initially shocked by how highly productive she could be in her own space.

However, as a Harvard Ph.D. student living alone, she soon faced a harsher reality: the profound social ramifications of days spent entirely in isolation.

This personal struggle inspired Harrington and her co-authors to investigate the broader trend, culminating in a massive study of over 580,000 workers published in the journal Science that links remote work to a major decline in mental health.

The study reveals that remote workers in the U.S. spend an average of one extra hour alone each day, translating to higher rates of mental distress, clinical therapy usage, and antidepressant prescriptions. Those living alone are hit hardest, facing an 83% spike in the likelihood of spending whole days without any human contact. As remote and hybrid models remain a permanent fixture of modern professional life, experts suggest that organizations must step up to combat this isolation, ensuring that remote flexibility does not come at the expense of human connection.

Source: Emanuel, N., Harrington, E., & Pallais, A. (2026). Home alone: Remote work, isolation, and mental health. Science (as presented by Hashem Al-Ghaili)

A company created a high-end single malt whisky made from diabetic people’s urine.

Living with type 1 diabetes himself, British designer James Gilpin created 'Gilpin Family Whisky' as an artistic exploration into the commodification of the human body.

Because diabetes compromises the body's ability to regulate blood glucose, patients with type 2 diabetes excrete significant amounts of sugar daily in their urine. Gilpin realized this abundant biological byproduct could serve as an alternative fermentation resource. Utilizing his own grandmother as his first donor to refine the process, he began collecting urine from elderly patients and individuals with aging endocrine systems.

To safely craft the bizarre blend, Gilpin filters the donated urine using methods similar to municipal water purification. The large, crystal-shaped sugar molecules are extracted, purified a second time, and mixed with a mash stock to accelerate fermentation. Once this is converted into a clear alcohol spirit, traditional whisky blends are introduced to give the final drink its signature color, taste, and viscosity. Far from a commercial product, the bespoke bottles—each labeled with the donor's name and age—serve as a provocative public engagement piece raising awareness about diabetes and sustainability.

Source: Yoneda, Y. Gilpin Family Whisky is Recycled from Diabetic's Urine. Inhabitat (as presented by Hashem Al-Ghaili).

We all know regular exercise is essential for good health, but according to new research, doing 90 minutes to two hours of weight training per week can cut the risk of an early death

Here's what the science says ⤵️
https://www.telegraph.co.uk/news/2026/06/03/two-weekly-gym-sessions-key-to-long-life/?WT.mc_id=tmgoff_fb_photo_sessions-key-to-long-life/

Source: The Telegraph

Doing 90 minutes to two hours of weight training per week can greatly reduce the risk of an early death, according to new research. Read why: https://bbc.in/3RKL9Nw

Source: BBC News

Scientists used CRISPR gene editing to remove the extra chromosome responsible for Down syndrome in human cells.

Down syndrome, also known as trisomy 21, affects approximately 1 in 700 births worldwide and has long been considered a permanent genetic condition. In a groundbreaking proof-of-concept study published in PNAS Nexus, scientists developed an allele-specific gene-editing approach using CRISPR-Cas9 to selectively cleave and eliminate the extra 21st chromosome.

Testing this technique on lab-grown cells—including induced pluripotent stem cells and skin fibroblasts derived from individuals with Down syndrome—the researchers achieved a major milestone: successfully restoring normal chromosome counts. Crucially, the treatment normalized cellular patterns and gene expression, demonstrating that the genetic imbalances behind the condition can be reversed at the cellular level.

While the scientific community is celebrating this achievement, experts emphasize that the treatment is still in its infancy and far from ready for human clinical trials. Deleting an entire chromosome in a living person carries severe risks of off-target genetic damage and unintended mutations. However, if researchers can refine the technique to make it safer and more precise, it could eventually be used to target specific cell types like neurons and glial cells, offering unprecedented avenues for early developmental or even in utero interventions. Beyond Down syndrome, this innovative technique holds transformative potential for other devastating chromosomal disorders, such as Edwards syndrome (trisomy 18) and Patau syndrome (trisomy 13), which are currently fatal for most infants.

Source: Hashizume, R., Wakita, S., Sawada, H., Takebayashi, S., Kitabatake, Y., Miyagawa, Y., Hirokawa, Y. S., Imai, H., & Kurahashi, H. (2025). Trisomic rescue via allele-specific multiple chromosome cleavage using CRISPR-Cas9 in trisomy 21 cells. PNAS Nexus, 4(2) (as presented by Hashem Al-Ghaili).

Breakthrough!

https://www.independent.co.uk/news/health/hiv-new-treatment-imperial-college-art-daily-pill-b2985055.html?fbclid=IwdGRjcASGLbZjbGNrBIYtj2V4dG4DYWVtAjExAHNydGMGYXBwX2lkDDM1MDY4NTUzMTcyOAABHlUaCqgSFgGbju03xD8o4i0jF4tGvq3v264i4j_DRrRYI7zDSSiGNuy_yUe1_aem_I5sBqUBZpX9lVK--9gieFw

Source: The Independent

Scientists Develop Nanorobots That Could Rebuild Human Teeth Naturally

Scientists are reportedly advancing nanotechnology systems that could one day help rebuild damaged teeth at a microscopic level without the need for traditional dental procedures.

These experimental nanorobots are designed to operate at a cellular scale, potentially targeting weakened enamel, cavities, and micro-damage within teeth. The concept is based on regenerative nanomedicine, where extremely small machines are guided to repair biological tissue by restoring minerals or stimulating natural rebuilding processes inside the tooth structure.

Researchers emphasize that this technology is still in early research and development stages, and no approved medical system currently allows autonomous nanorobots to perform full dental reconstruction in humans. Most current studies are limited to simulations, lab environments, and preliminary material science experiments.

If developed successfully in the future, such innovations could transform dentistry by reducing the need for drilling, fillings, and invasive procedures. Instead of treating damage after it occurs, the focus could shift toward continuous microscopic repair, potentially improving long term oral health and reducing dental disease globally.

While still theoretical, this research reflects how rapidly nanotechnology is evolving and how it may reshape medical treatment in the coming decades.



Source: the universe

We may have gotten B12 all wrong — and it could be leading to brain damage.

Researchers at the University of California, San Francisco, have discovered that older adults with vitamin B12 levels currently considered "normal" may still be suffering from silent brain damage.

The study found that individuals with lower active B12—even those well above the federal deficiency cutoff—exhibited slower processing speeds and delayed visual responses. Most concerning were MRI results showing increased lesions in the brain's white matter, the critical nerve fibers that act as communication highways between different brain regions.

These findings suggest that current clinical thresholds for B12 deficiency are too blunt to capture early neurological decline. Dr. Ari J. Green, the study's senior author, emphasizes that the definition of deficiency needs to be revisited to include functional biomarkers, potentially allowing for earlier intervention through supplementation. While B12 is vital for DNA and red blood cell production, this research highlights that what is deemed "statistically normal" in a lab report may not be "optimal" for maintaining cognitive health during the aging process.

Source: University of California - San Francisco. (2026). Hidden Vitamin B12 Brain Risk: UCSF Study Suggests Normal Levels May Be Too Low for Brain Health. Annals of Neurology (as presented by Hashem Al-Ghaili).